Phase 3 Readout~month

Phase 3 Topline: A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase 3 Study Evaluating Efficacy and S

Indication
NASH - Nonalcoholic Steatohepatitis

Other upcoming events for IVA

Patent ExpiryPatent/Exclusivity Expiry: DRIZALMA SPRINKLE

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase 3 Study Evaluating Efficacy and S — IVA Phase 3 Readout | BioSniper